PeterSinger comments on Fact checking comparison between trachoma surgeries and guide dogs - Effective Altruism Forum

You are viewing a comment permalink. View the original post to see all comments and the full post content.

Comments (27)

You are viewing a single comment's thread. Show more comments above.

Comment author: saulius  (EA Profile) 13 May 2017 02:01:41PM *  4 points [-]

EDIT: this comment contains some mistakes

To begin with, I want to say that my goal is not to put blame on anyone but to change how we speak and act in the future.

His figure for the cost of preventing blindness by treating trachoma comes from Joseph Cook et al., “Loss of vision and hearing,” in Dean Jamison et al., eds., Disease Control Priorities in Developing Countries, 2d ed. (Oxford: Oxford University Press, 2006), 954. The figure Cook et al. give is $7.14 per surgery, with a 77 percent cure rate.

I am looking at this table from the cited source (Loss of Vision and Hearing, DCP2). It’s 77% cure rate for trachoma that sometimes develops into blindness. Not 77% cure rate for blindness. At least that’s how I interpret it, I can’t be sure because the cited source of the figure in the DCP2’s table doesn’t even mention trachoma! From what I’ve read, sometimes recurrences happen so 77% cure rate from trachoma is much much more plausible. I'm afraid Toby Ord made the mistake of implying that curing trachoma = preventing blindness.

What is more, Toby Ord used the same DCP2 report that GiveWell used and GiveWell found major errors in it. To sum up very briefly:

Eventually, we were able to obtain the spreadsheet that was used to generate the $3.41/DALY estimate. That spreadsheet contains five separate errors that, when corrected, shift the estimated cost effectiveness of deworming from $3.41 to $326.43. [...] The estimates on deworming are the only DCP2 figures we’ve gotten enough information on to examine in-depth.

Regarding Fred Hollows Foundation, please see GiveWell’s page about them and this blog post. In my eyes these discredit organization’s claim that it restores sight for $25.

In conclusion, without further research we have no basis for the claim that trachoma surgeries can prevent 400, or even 40 cases of blindness for $40,000. We simply don't know. I wish we did, I want to help those people in the video.

I think one thing that is happening is that we are too eager to believe any figures we find if they support an opinion we already hold. That severely worsens already existing problem of optimizer’s curse.

I also want to add that preventing 400 blindness cases for $40,000 (i.e. one case for $100) to me sounds much more effective than top GiveWell's charities. GiveWell seem to agree, see citations from this page

Based on very rough guesses at major inputs, we estimate that cataract programs may cost $112-$1,250 per severe visual impairment reversed [...] Based on prior experience with cost-effectiveness analyses, we expect our estimate of cost per severe visual impairment reversed to increase with further evaluation. [...] Our rough estimate of the cost-effectiveness of cataract surgery suggests that it may be competitive with our priority programs; however, we retain a high degree of uncertainty.

We tell the trachoma example and then advertise GiveWell, showing that GiveWell’s top and standout charities are not even related to blindness and no one in EA ever talks about blindness. So people probably assume that GiveWell’s recommended charities are much more effective than surgery that cures blindness for $100 but they are not.

Because GiveWell’s estimates for cataract surgeries are based on guesses, I think we shouldn’t use those figures in introductory EA talks as well. We can tell the disclaimers but the person who hears the example might skip them when retelling the thought experiment (out of desire to sound more convincing). And then the same will happen.

Comment author: PeterSinger 13 May 2017 11:47:33PM 7 points [-]

These are good points and I'm suitably chastened for not being sufficiently thorough in checking Toby Ord's claims,
I'm pleased to see that GiveWell is again investigating treating blindness: http://blog.givewell.org/2017/05/11/update-on-our-views-on-cataract-surgery/. In this very recent post, they say: "We believe there is evidence that cataract surgeries substantially improve vision. Very roughly, we estimate that the cost-effectiveness of cataract surgery is ~$1,000 per severe visual impairment reversed.[1]"
The footnote reads: "This estimate is on the higher end of the range we calculated, because it assumes additional costs due to demand generation activities, or identifying patients who would not otherwise have known about surgery. We use this figure because we expect that GiveWell is more likely to recommend an organization that can demonstrate, through its demand generation activities, that it is causing additional surgeries to happen. The $1,000 figure also reflects our sense that cost-effectiveness in general tends to worsen (become more expensive) as we spend more time building our model of any intervention. Finally, it is a round figure that communicates our uncertainty about this estimate overall. But it's reasonable to say that until they complete this investigation, which will be years rather than months, it may be better to avoid using the example of preventing or curing blindness." So the options seem to be either not using the example of blindness at all, or using this rough figure of $1000, with suitable disclaimers. It still leads to 40 cases of severe visual impairment reversed v. 1 case of providing a blind person with a guide dog.

Comment author: saulius  (EA Profile) 14 May 2017 10:57:35AM 2 points [-]

agree :)